Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M97.0Revenue (TTM) $M25.3Net Margin (%)-77.4Altman Z-Score-5.7
Enterprise Value $M90.5EPS (TTM) $-0.8Operating Margin %-57.5Piotroski F-Score5
P/E(ttm)--Beneish M-Score-2.6Pre-tax Margin (%)-76.8Higher ROA y-yY
Price/Book2.910-y EBITDA Growth Rate %--Quick Ratio3.4Cash flow > EarningsY
Price/Sales2.85-y EBITDA Growth Rate %--Current Ratio3.8Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-33.5Higher Current Ratio y-yY
Dividend Yield %--PEG--ROE % (ttm)-76.7Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M31.9ROIC % (ttm)-70.9Gross Margin Increase y-yY

Gurus Latest Trades with CRME

Number of guru portfolios checked: 69.
Ticker Guru Date Action
Impact Price Range
(Average)*
Current Price Change from Average Comment Current Shares

CRME is held by these investors:



CRME: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Archibald, JenniferSenior Officer 2014-09-08Buy75$7.29-58.3view
Archibald, JenniferSenior Officer 2014-09-05Buy4,100$7.25-58.07view
Archibald, JenniferSenior Officer 2014-09-05Buy100$7.22-57.89view
Archibald, JenniferSenior Officer 2014-09-05Buy3,259$6.7-54.63view
Hunter, William L.Director, Senior Officer 2014-09-05Buy31,000$6.74-54.9view
Hunter, William L.Director, Senior Officer 2014-09-04Buy19,000$6.65-54.29view
RIEDER, ROBERTDirector, Director or Senior Officer of Insider or 2014-06-27Sell2,000$8.65-64.86view
RIEDER, ROBERTDirector, Director or Senior Officer of Insider or 2014-06-26Sell1,500$8.65-64.86view
RIEDER, ROBERTDirector, Director or Senior Officer of Insider or 2014-06-25Sell300$8.63-64.77view
RIEDER, ROBERTDirector, Director or Senior Officer of Insider or 2014-06-25Sell2,000$8.64-64.81view

Press Releases about CRME :

Quarterly/Annual Reports about CRME:

    News about CRME:

    Articles On GuruFocus.com
    A Closer Look Into Veritas Pharma Apr 21 2016 
    Julian Robertson’s "smart idea, grounded on exhaustive research, followed by a big bet" Jun 24 2011 
    Julian Robertson’s Tiger Management Q1 Portfolio Update May 16 2011 
    Julian Robertson Keeps Buying CRME, Selling AAPL Apr 13 2011 
    More Word of Wisdom from Julian Robertson; Top 2Q10 Purchases: GOOG, EBAY, AAPL, CRME, GS Nov 04 2010 

    More From Other Websites
    Cardiome Pharma Corp. :CRME-US: Earnings Analysis: Q4, 2016 By the Numbers : March 20, 2017 Mar 20 2017
    Cardiome Pharma Corp. :CRME-US: Earnings Analysis: 2016 By the Numbers : March 16, 2017 Mar 16 2017
    Cardiome Receives Notice of Compliance from Health Canada for its BRINAVESS NDS Mar 14 2017
    Cardiome Receives Notice of Compliance from Health Canada for its BRINAVESS NDS Mar 14 2017
    Cardiome reports 4Q loss Mar 07 2017
    Cardiome reports 4Q loss Mar 07 2017
    Cardiome Reports Fourth Quarter and Full Year 2016 Financial Results Mar 07 2017
    Cardiome Reports Fourth Quarter and Full Year 2016 Financial Results Mar 07 2017
    Cardiome Announces Commercial Launch of Xydalba™ (dalbavancin) in France Mar 03 2017
    Cardiome Announces Commercial Launch of Xydalba™ (dalbavancin) in France Mar 03 2017
    Cardiome To Hold Fourth Quarter And Full Year 2016 Financial Results Conference Call On March 7 Feb 27 2017
    Cardiome To Hold Fourth Quarter And Full Year 2016 Financial Results Conference Call On March 7 Feb 27 2017
    Cardiome Announces Commercial Launch of XYDALBA™ (dalbavancin) in Germany Dec 20 2016
    Cardiome Announces Commercial Launch of XYDALBA™ (dalbavancin) in Germany Dec 20 2016
    Is CARDIOME PHARMA CORP (CRME) a Good Stock to Buy? Dec 13 2016
    Cardiome Announces Commercial Launch of Xydalba™ (dalbavancin) in the UK Dec 08 2016
    Cardiome Announces Commercial Launch of Xydalba™ (dalbavancin) in the UK Dec 08 2016
    Cardiome Advances Toward the UK XYDALBA™ (dalbavancin) Launch Nov 29 2016
    Cardiome Advances Toward the UK XYDALBA™ (dalbavancin) Launch Nov 29 2016
    Cardiome Pharma Corp. :CRME-US: Earnings Analysis: Q3, 2016 By the Numbers : November 9, 2016 Nov 09 2016

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)